MMRGlobal Discloses $17MM Pipeline From MMRPro in Filing of
MMRGlobal Discloses $17MM Pipeline From MMRPro in Filing of Third Quarter Results
LOS ANGELES, CA -- (Marketwire) -- 11/15/12 -- MMRGlobal, Inc. (OTCQB: MMRF) ("MMR") today announced that as reported in yesterday's quarterly filing on Form 10-Q for the period ended September 30, 2012, a minimum performance purchase Agreement was signed with VisiInc PLC ("Visi") for the sale of MMRPro systems. The VISI MMRPro bundle was launched to a network of hundreds of Value Added Resellers ("VARs") in Las Vegas this week. Additional presentations were made at the Verizon/Alcatel-Lucent Healthcare and Life Science Symposium which was also held this week in Las Vegas. The Agreement with VisiInc, valued at a minimum of $17 million dollars, calls for selling MMRPro with other Visi products collectively being sold as VISI MMRPro through resellers of medical products and services to healthcare professionals. The VISI MMRPro systems are part of a Visi/MMR/Via3 product bundle being sold through a syndicate of VARs. A copy of the signed Agreement is included in the Company's most recent filing with the SEC.
The VISI MMRPro system is also being sold to dentists through a major wholesaler of dental products and services, which has an estimated 24,000 dental office clients. Visi and the wholesaler have already begun the process of installing VISI MMRPro systems in several of its dental clients' offices. The Visi offering also includes external storage drives, which when connected to the VISI MMRPro system will store documents and images created in the VISI MMRPro system in the storage drives, as well as in MMRPro.
About MMRGlobal, Inc.
MMRGlobal, Inc., through its wholly-owned operating subsidiary, MyMedicalRecords, Inc. ("MMR") (www.mymedicalrecords.com), provides secure and easy-to-use online Personal Health Records ("PHRs") and electronic safe deposit box storage solutions, serving consumers, healthcare professionals, employers, insurance companies, financial institutions, and professional organizations and affinity groups. MyMedicalRecords enables individuals and families to access their medical records and other important documents, such as birth certificates, passports, insurance policies and wills, anytime from anywhere using the Internet. The MyM edicalRecords Personal Health Record is built on proprietary, patented technologies to allow documents, images and voicemail messages to be transmitted and stored in the system using a variety of methods, including fax, phone, or file upload without relying on any specific electronic medical record platform to populate a user's account. The Company's professional offering, MMRPro, is designed to give physicians' offices an easy and cost-effective solution to digitizing paper-based medical records and sharing them with patients in real time through an integrated patient portal. MMR is an Independent Software Vendor Partner with Kodak to deliver an integrated turnkey EMR solution for healthcare professionals. Through its merger with Favrille, Inc. in January 2009, the Company acquired intellectual property biotech assets that include anti-CD20 antibodies and data and samples from its FavId(TM)/Specifid(TM) vaccine clinical trials for the treatment of B-Cell Non-Hodgkin's lymphoma. To learn more about MMRGlobal, Inc. and its products, visit www.mmrglobal.com.
Statements in this press release that are not strictly historical in nature, including but not limited to agreements with VisiInc PLC and the VISI MMRPro system launch, and the Company's future performance, management's expectations, beliefs, intentions, estimates or projections, constitute "forward-looking statements." Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the Company's actual results to be materially different from historical results or from any results expressed or implied by such forward-looking statements. Some can be identified by the use of words (and their derivations) such as "need," "possibility," "offer," "development," "if," "negotiate," "when," "begun," "believe," "achieve," "will," "estimate," "expect," "could," "maintain," "plan," and "continue," or the negative of these words. Factors that could cause or contribute to such differences include, but are not limited to, the risk the Company's products are not adopted or viewed favorably by the healthcare community; risks related to the current uncertainty and instability in financial and lending markets, including global economic uncertainties; variations in our quarterly operating results; product integration in physician practices, surgery centers, hospitals and other healthcare facilities; timing and volume of sales and installations, including VISI MMRPro; length of sales cycles and the installation process; market acceptance of new product introductions; ability to establish and maintain strategic relationships; ability to identify and integrate acquisitions; relationships with licensees; competitive product offerings and promotions; changes in government laws and regulations and future changes in tax legislation and initiatives in the healthcare industry, both in the U.S. and internationally; undetected errors in our products; possibility of interruption at our data centers; risks related to third party vendors; risks related to obtaining and integrating third-party licensed technology; acceptance of the Company's marketing and promotional campaigns; risks related to a security breach by third parties; maintaining, developing, defending and monetizing our intellectual property rights including those pertaining to our biotechnology assets; risks associated with recruitment and retention of key personnel; litigation matters; uncertainties associated with doing business internationally across borders and territories; and additional risks discussed in the Company's filings with the Securities and Exchange Commission. The Company is providing this information as of the date of this release and, except as required by law, does not undertake any obligation to update any forward-looking statements contained in this release as a result of new information, future events or otherwise.
Michael Selsman Public Communications Co. (310) 922-7033 email@example.com